Eric L. Dobmeier
2016
In 2016, Eric L. Dobmeier earned a total compensation of $3.7M as Chief Operating Officer at Seattle Genetics, a 65% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $261,800 |
---|---|
Option Awards | $1,534,003 |
Salary | $453,639 |
Stock Awards | $1,433,700 |
Other | $12,405 |
Total | $3,695,547 |
Dobmeier received $1.5M in option awards, accounting for 42% of the total pay in 2016.
Dobmeier also received $261.8K in non-equity incentive plan, $453.6K in salary, $1.4M in stock awards and $12.4K in other compensation.
Rankings
In 2016, Eric L. Dobmeier's compensation ranked 2,471st out of 14,075 executives tracked by ExecPay. In other words, Dobmeier earned more than 82.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,471 out of 14,075 | 82nd |
Division Manufacturing | 850 out of 5,489 | 85th |
Major group Chemicals And Allied Products | 248 out of 1,895 | 87th |
Industry group Drugs | 179 out of 1,538 | 88th |
Industry Biological Products, Except Diagnostic Substances | 38 out of 279 | 86th |
Source: SEC filing on April 5, 2017.
Dobmeier's colleagues
We found six more compensation records of executives who worked with Eric L. Dobmeier at Seattle Genetics in 2016.
2016
Clay Siegall
Seattle Genetics
Chief Executive Officer
2016
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2016
Vaughn Himes
Seattle Genetics
Chief Technical Officer
2016
Darren Cline
Seattle Genetics
Former Executive Vice President, Commercial
2016
Todd Simpson
Seattle Genetics
Chief Financial Officer
2016
Jean Liu
Seattle Genetics